Allied Market Research
Upcoming Allied Market Research
Patient Blood Management Market

Patient Blood Management Market: Global Opportunity Analysis and Industry Forecast, 2019–2026

Pages: NA
Dec 2021 | 214 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Patient Blood Management Market

Request Now !

Patient Blood Management Market Report Overview:

Patient blood management (PBM) is a standard of care in surgery and medicine which is utilized to maximize the use of a patient’s own blood and ensure to avoid unnecessary blood transfusions during a surgery. It improves patient outcomes by making sure that the focus on the patient’s medical and surgical management is on improving and preserving the patient’s own blood. Consequently, patients usually require less transfusions of donor blood, thus dropping the risk of transfusion associated complications. Furthermore, PBM helps to conserve one’s own blood during surgery or medical treatments which have a known risk of blood loss and hence reduces the complications. It involves three principles mainly, to optimize recovery, ensure reduction in the blood loss during the treatment and to optimize a patient’s blood levels before a surgical or medical treatment.

Patient Blood Management Market scope and structure analysis:

Report Metric


  Market size available for years


  Base year considered


  Forecast period


  Forecast units

  Value (USD)

  Segments covered

  Product, Component, End User and Region

  Geographies covered

North America (US and Canada), Europe (Germany, UK, France, and the Rest of Europe), Asia Pacific (China, Japan, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM) and The Middle East and Africa

  Companies covered

Major players analyzed include Bio-Rad Laboratories, Inc., Haemonetics Corporation, Terumo Corporation, Asahi Kasei Corporation, Immucor, Inc., B. Braun Melsungen AG, Macopharma, Abbott Laboratories, Grifols, Fresenius SE & Co. KGaA, S.A., F. Hoffmann-La Roche LTD, Haier Biomedical, LivaNova PLC, Mediware Information Systems, and Danaher Corporation.


COVID-19 scenario analysis:

Coronavirus disease 2019 (COVID-19) outbreak has caused an economic crisis along with a health care crisis. Furthermore, COVID-19 pandemic has stretched healthcare system globally, developed countries are anticipated to cause economic recession. The Covid-19 pandemic has drastically affected healthcare system, resulting in 50% to 70% drop in revenue from March. There are many small hospitals, clinics and nursing homes, which have been forced to shut their operations and hence reduction in the number of surgical procedures was observed. The stipulated lockout situation has caused resource limitation and hence would adversely affect the healthcare industry. In addition, visa cancellations have led to a gap in medical tourism and can negatively impact the healthcare services patient blood management market growth.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The key factors which are anticipated to help the market boost is expected to be rise in the prevalence of blood disorders among global population and surge in the number of blood donors and blood donations would boost the industry in the near future. Furthermore, the increase in the prevalence of the target diseases and the increased focus on the technological advancements in the patient blood managements market would help the industry gain maximum shares in the coming years. However, the higher cost of the instruments may hinder the growth of the industry in the commenced period.

New product launches to flourish the market

The key market players are focusing on showing their presence in the market by launching various advanced products, which would help the patient blood management market grow in the coming years. For instance, in July 2019, Abbott announced that U.S. Food and Drug Administration (FDA) had approved its new blood and plasma screening Alinity s System.  This novel solution is expected to bring the latest screening technology to U.S. blood and plasma centers. It is designed such that it could screen blood and plasma more efficiently within a smaller space than commercially available competitive systems. In a testing specialty that needs extensive hands-on time, the additional automation and flexibility of Alinity s will help blood and plasma centers improve the productivity and maintain the highest levels of accuracy.

Furthermore, in September 2019, Roche announced that it had received approval from the U.S. Food and Drug Administration (FDA) for the cobas Babesia test which can be used on the cobas 6800/8800 Systems for individual blood donation testing. It is Roche’s first commercially available whole blood test to screen donations and is followed by May 2019 FDA-updated industry guidance recommending screening and testing for Babesia, to lessen the risk of transmitting the parasite through transfusions.

Surge in mergers and acquisitions to boost the patient blood management market

The rise in the number of mergers and acquisitions would help the key market leaders to expand through a bigger distribution channel and hence boost the market in the near future. For instance, in July 2018, B. Braun Medical Inc. (B. Braun), which is a market leader in infusion therapy, renal therapies, and pain management, had signed an agreement to acquire the bloodlines business operated under the Medisystems name by NxStage Medical, Inc., which is a medical technology company based in Lawrence, Massachusetts (NxStage). This acquisition will help B. Braun to expand its territory and hence help the market gain maximum revenue.

Additionally, in February 2018, Terumo BCT announced that it will be the exclusive distributor for Stafa Cellular Therapy (StafaCT), which is a U.S.-based software developer. StafaCT software supports healthcare facilities and also cell labs as they manage each phase of the cellular therapy process including cell collection, patient referral, and processing, transplant and follow-up. Terumo BCT is also among the global leader in therapeutic apheresis, blood component, and cellular technologies. StafaCT and Sarah Cannon Blood Cancer Network co-developed software to achieve the managements of each phase of the transplant process.

Key segments covered:




  • Blood Transfusion Devices
  • Blood Processing Devices
  • Blood Cell Processors
  • Centrifuge
  • Blood Culture Screening Devices
  • Automated Blood Culture Systems
  • Supporting Equipment
  • Blood Storage Devices
  • Refrigerator
  • Freezers
  • Diagnostic & Testing Instruments
  • Accessories
  • Reagents and Kits
  • Others


  • Whole Blood
  • Blood Components

  End User

  • Hospitals
  • Blood Banks


Key benefits of the report:

  • This study presents the analytical depiction of the global Patient Blood Management industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Patient Blood Management market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global Patient Blood Management market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Patient Blood Management market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Patient Blood Management Market research report:

  • What are the leading market players active in the Patient Blood Management market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in tasking further strategic steps?
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Patient Blood Management Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995  $8,996
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers